Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report

BACKGROUND: Nivolumab is a monoclonal antibody against programmed death 1 and has become a standard treatment of advanced melanoma because of its durable response and survival benefits. In this report, we present a case of severe intestinal perforation after nivolumab immunotherapy for malignant mel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Surg Case Rep
Glavni autori: Yasuda, Koji, Tanaka, Toshiaki, Ishihara, Soichiro, Otani, Kensuke, Nishikawa, Takeshi, Kiyomatsu, Tomomichi, Kawai, Kazushige, Hata, Keisuke, Nozawa, Hiroaki, Masui, Yuri, Shintani, Yukako, Watanabe, Toshiaki
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572476/
https://ncbi.nlm.nih.gov/pubmed/28842844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0370-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items